An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.
Shantell M. Kirkendoll
Shantell M. Kirkendoll is the senior communication representative for the University of Michigan Health System. She leverages social media and media relations to tell compelling stories about research and health care. She was a Knight Journalism Fellow at the Centers for Disease Control and Prevention and joined the University of Michigan Health System in 2009. Prior to that she was a print journalist for 20 years.
A newly approved stent designed to treat glaucoma is a new option for some patients at U-M’s Kellogg Eye Center, one of the first centers in the country to offer it.
Ophthalmologists urge providers to stop prescribing antibiotics for a common eye condition that typically clears up without medication.
A study drug safely minimizes severity for those with a painful eye condition, a new clinical trial at the University of Michigan Kellogg Eye Center has found.
A study including more than 4,000 people with either type 1 or type 2 diabetes — all under age 21 — revealed a troubling eye health trend.
With input from U-M trauma experts, elderly and obese dummies are being used to help car manufacturers create safer vehicles for today’s drivers.